Scholarlink

<p>To systematically evaluate the benefits and safety of implementing ERAS protocols in patients undergoing robot-assisted renal surgery. We conducted a systematic review and meta-analysis following the PRISMA 2020 guidelines. PubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from database inception to the most recent update to identify studies comparing ERAS with conventional care in robot-assisted partial nephrectomy, radical nephrectomy, or nephroureterectomy. To synthesize the results, random-effects models were applied, with continuous outcomes expressed as weighted mean differences (WMDs) and dichotomous outcomes as odds ratios (ORs). Five studies (1 randomized controlled trial and 4 retrospective cohorts) involving 1,483 patients were included (730 ERAS; 753 traditional care). ERAS care was associated with patients spending less time in the hospital (WMD = − 0.91 days, 95% CI: −1.77, − 0.05; P &lt; 0.05). Operative time (WMD = − 14.4 min, 95% CI: −30.33, 1.53; P = 0.324), overall postoperative complications (OR = 0.78, 95% CI: 0.30, 2.03; P = 0.843), and readmission (OR = 0.80, 95% CI: 0.18, 3.56; P = 0.069) were not significantly different between groups. In robot-assisted renal surgery, ERAS protocols shorten hospitalization without increasing operative time, postoperative complications, or readmission. Larger, well-designed multicenter trials with standardized ERAS elements and compliance reporting are warranted.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Enhanced recovery after surgery in robot-assisted renal surgery: a systematic review and meta-analysis

  • 期刊论文

  • 发表日期：

    2026年2月7日

查看全文
  • Yalin Yu,
  • Ziying Li,
  • Yao Zhang,
  • Qin Qin

摘要

To systematically evaluate the benefits and safety of implementing ERAS protocols in patients undergoing robot-assisted renal surgery. We conducted a systematic review and meta-analysis following the PRISMA 2020 guidelines. PubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from database inception to the most recent update to identify studies comparing ERAS with conventional care in robot-assisted partial nephrectomy, radical nephrectomy, or nephroureterectomy. To synthesize the results, random-effects models were applied, with continuous outcomes expressed as weighted mean differences (WMDs) and dichotomous outcomes as odds ratios (ORs). Five studies (1 randomized controlled trial and 4 retrospective cohorts) involving 1,483 patients were included (730 ERAS; 753 traditional care). ERAS care was associated with patients spending less time in the hospital (WMD = − 0.91 days, 95% CI: −1.77, − 0.05; P < 0.05). Operative time (WMD = − 14.4 min, 95% CI: −30.33, 1.53; P = 0.324), overall postoperative complications (OR = 0.78, 95% CI: 0.30, 2.03; P = 0.843), and readmission (OR = 0.80, 95% CI: 0.18, 3.56; P = 0.069) were not significantly different between groups. In robot-assisted renal surgery, ERAS protocols shorten hospitalization without increasing operative time, postoperative complications, or readmission. Larger, well-designed multicenter trials with standardized ERAS elements and compliance reporting are warranted.